BRIEF published on 10/13/2026 at 09:05, 28 days 22 hours ago Eckert & Ziegler's Market Position and Growth Potential Investment Opportunity Eckert & Ziegler SE Isotope Supply CDMO Sales Radiopharma Market
PRESS RELEASE published on 10/13/2026 at 09:00, 28 days 22 hours ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY Recent acquisition activities in radiopharma industry highlight the value of Eckert & Ziegler SE's core capabilities. Independent isotope supply and specialist manufacturing make it an attractive BUYing opportunity Acquisition Eckert & Ziegler SE Isotope Supply Radiopharma Specialist Manufacturing
BRIEF published on 08/14/2026 at 09:05, 2 months 27 days ago Eckert & Ziegler SE : Une croissance solide malgré les défis Évaluation Des Actions Produits Isotopiques Croissance Médicale Eckert Et Ziegler Résultats Du Premier Semestre 2026
BRIEF published on 08/14/2026 at 09:05, 2 months 27 days ago Eckert & Ziegler SE: Solid Growth Despite Challenges Eckert & Ziegler Stock Valuation Isotope Products Medical Growth H1 2026 Results
PRESS RELEASE published on 08/14/2026 at 09:00, 2 months 27 days ago Original-Research: Eckert & Ziegler SE (von NuWays AG): BUY NuWays AG releases updated research classified Eckert & Ziegler SE as a BUY with target price EUR 21.5. H1 results show solid growth in medical and isotope products segments with confirmed FY26 guidance Buy Recommendation NuWays AG Eckert & Ziegler SE H1 Results FY26 Guidance
BRIEF published on 08/13/2026 at 07:50, 2 months 28 days ago Eckert & Ziegler maintient le cap au premier semestre 2026 Résultats Financiers Prévisions De Bénéfices Segment Médical Eckert Et Ziegler Premier Semestre 2026
BRIEF published on 08/13/2026 at 07:50, 2 months 28 days ago Eckert & Ziegler Maintains Course in First Half of 2026 Financial Results Eckert & Ziegler Profit Forecast Medical Segment First Half 2026
PRESS RELEASE published on 08/13/2026 at 07:45, 2 months 28 days ago Eckert & Ziegler Remains on Track in the First Half of 2026 Eckert & Ziegler SE reports stable financial results for the first half of 2026 with sales of €149.3 million and net income of €22.4 million. The company confirms its forecast for the year 2026 Financial Results Sales Forecast Eckert & Ziegler SE First Half 2026
BRIEF published on 07/23/2026 at 09:06, 3 months 18 days ago Competitive Dynamics in the Radiopharmaceutical Market: Eckert & Ziegler's Strategy Eckert & Ziegler Radiopharmaceuticals Competition Lu-177 Growth Ga-68 Market
BRIEF published on 07/23/2026 at 09:06, 3 months 18 days ago Dynamique concurrentielle sur le marché des produits radiopharmaceutiques : la stratégie d'Eckert & Ziegler Produits Radiopharmaceutiques Concours Eckert Et Ziegler Croissance Lu-177 Marché Ga-68
Published on 11/11/2026 at 03:30, 3 hours 50 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 6 hours 40 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 7 hours 50 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 8 hours 20 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 8 hours 20 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 07:00, 19 minutes ago Swiss Life continues on its growth path: higher fee income and premiums in the first nine months of 2026
Published on 11/11/2026 at 07:00, 19 minutes ago Swiss Life poursuit sa croissance : hausse des revenus issus de frais et commissions et des recettes de primes sur les neuf premiers mois de 2026
Published on 11/11/2026 at 07:00, 20 minutes ago SoftwareOne delivers solid growth and margin expansion in Q3 2026; FY 2026 profitability guidance raised
Published on 11/11/2026 at 07:00, 20 minutes ago KWS posts good start to fiscal year 2026/2027 and confirms forecasts
Published on 11/11/2026 at 07:00, 20 minutes ago E.ON reaffirms 2026 guidance and continues to invest in Europe’s energy infrastructure
Published on 11/10/2026 at 18:00, 13 hours 20 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 13 hours 35 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 13 hours 45 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 13 hours 48 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
